Impacto del consumo de canela sobre la glicemia sérica en pacientes con Diabetes Mellitus tipo 2: Una revisión de la literatura
Palabras clave:
Diabetes, Diabetes mellitus tipo II, Síndrome metabólico, Canela, CinamaldehídoResumen
Introducción: La DM tipo 2 se considera una de las enfermedades crónicas no transmisibles más prevalentes en el mundo. El tratamiento de esta enfermedad incluye medidas no farmacológicas, dentro de las cuales la alimentación es un blanco importante de estudio; uno de los alimentos que podría adquirir relevancia es la canela, compuesta por elementos bioactivos que podrían contribuir al control de la glicemia. Considerando el potencial clínico que demuestra la canela, el objetivo de esta revisión es determinar el posible impacto del consumo de canela en la glicemia sérica de pacientes con DM tipo 2. Materiales y métodos: Se realizó una revisión de la literatura con base en información encontrada en las bases de datos de PubMed, Science Direct y Google Académico y se tuvieron en cuenta artículos publicados entre los años 2006 y 2022 como revisión de la literatura y metaanálisis, que incluyeran información sobre la evidencia clínica del consumo de canela y el impacto en marcadores clínicos de relevancia como la glicemia en sangre, el perfil lipídico y el IMC. Resultados: En la información recopilada se evidenció que los componentes de la canela podrían actuar adecuadamente en el proceso de señalización de la insulina y que el uso de la canela podría disminuir los niveles de glicemia en pacientes con un manejo farmacológico previamente instaurado. Por otro lado, se encontró que el consumo de canela en estos pacientes no mostró efectos adversos o empeoramiento de la enfermedad. Conclusión: A pesar de que se documentan estudios que evidencian el impacto de la canela en la glicemia sérica, aún no hay evidencia suficiente que corrobore el impacto de esta molécula como factor hipoglicemiante. Sin embargo, los hallazgos encontrados no descartan el uso de la canela como factor coadyuvante en la terapia farmacológica para pacientes con DM tipo 2.
Descargas
Citas
Organización Mundial de la Salud OMS. Diabetes [Internet]. 2016. Disponible en: https://www.who.int/es/news-room/fact-sheets/detail/diabetes
Harreiter J, Roden M. Diabetes mellitus-Definition, classification, diagnosis, screening and prevention (Update 2019). Wien Klin Wochenschr. 2019; 131(S 01):6-15. DOI: 10.1007/s00508-019-1450-4.
American Diabetes Association. Diagnosis and classification of diabetes mellitus. Diabetes Care. 2013; 36(S 01):S67-74. DOI: 10.2337/dc13-S067.
Glovaci D, Fan W, Wong ND. Epidemiology of Diabetes Mellitus and Cardiovascular Disease. Curr Cardiol Rep. 2019; 21(4):21. DOI: 10.1007/s11886-019-1107-y.
International Diabetes Federation. IDF Diabetes Atlas | Tenth Edition. Disponible en: https://diabetesatlas.org/
Roden M. Diabetes mellitus: definition, classification and diagnosis. Wien Klin Wochenschr. 2016; 128 Suppl 2:S37-40. DOI: 10.1007/s00508-015-0931-3.
Inzucchi, Silvio E, Lupsa, Beatrice. Clinical presentation, diagnosis, and initial evaluation of diabetes mellitus in adults - UpToDate. Disponible en: https://www.uptodate.com/contents/clinical-presentation-diagnosis-and-initial-evaluation-of-diabetes-mellitus-in-adults?search=diabetes%20mellitus%20tipo%202%20diagnosis&source=search_result&selectedTitle=1~150&usage_type=default&display_rank=1
Landgraf R, Aberle J, Birkenfeld AL, Gallwitz B, Kellerer M, Klein H, et al. Therapy of Type 2 Diabetes. Exp Clin Endocrinol Diabetes Off J Ger Soc Endocrinol Ger Diabetes Assoc. 2019; 127(S 01):S73-92. DOI: 10.1055/a-1018-9106.
Cano Rodríguez I, Ballesteros Pomar MD. Alternative therapies in diabetes. Endocrinol Diabetes Nutr. 2018; 65(4):189-91. DOI: 10.1016/j.endonu.2018.03.001.
Pedrero V, Manzi J, Alonso LM. A Cross-Sectional Analysis of the Stigma Surrounding Type 2 Diabetes in Colombia. Int J Environ Res Public Health. 2021; 18(23):12657. DOI: 10.3390/ijerph182312657.
Gottlieb PA, Michels AW. Advances in Diabetes Treatment - Once-Weekly Insulin. N Engl J Med. 2020; 383(22):2171-2. DOI: 10.1056/NEJMe2031596.
Zare R, Nadjarzadeh A, Zarshenas MM, Shams M, Heydari M. Efficacy of cinnamon in patients with type II diabetes mellitus: A randomized controlled clinical trial. Clin Nutr. 2019; 38(2):549-56. DOI: 10.1016/j.clnu.2018.03.003.
Ranasinghe P, Pigera S, Premakumara GS, Galappaththy P, Constantine GR, Katulanda P. Medicinal properties of ‘true’ cinnamon (Cinnamomum zeylanicum): a systematic review. BMC Complement Altern Med. 2013; 13(1):275. DOI: 10.1186/1472-6882-13-275.
Costello RB, Dwyer JT, Saldanha L, Bailey RL, Merkel J, Wambogo E. Do Cinnamon Supplements Have a Role in Glycemic Control in Type 2 Diabetes? A Narrative Review. J Acad Nutr Diet. 2016; 116(11):1794-802. DOI: 10.1016/j.jand.2016.07.015.
Błaszczyk N, Rosiak A, Kałużna-Czaplińska J. The Potential Role of Cinnamon in Human Health. Forests. 2021; 12(5):648. DOI: 10.3390/f12050648.
Allen RW, Schwartzman E, Baker WL, Coleman CI, Phung OJ. Cinnamon Use in Type 2 Diabetes: An Updated Systematic Review and Meta-Analysis. Ann Fam Med. 2013; 11(5):452-9. DOI: 10.1370/afm.1517.
Kim Y, Keogh JB, Clifton PM. Polyphenols and Glycemic Control. Nutrients. 2016; 8(1):17. DOI: 10.3390/nu8010017.
Crawford P. Effectiveness of cinnamon for lowering hemoglobin A1C in patients with type 2 diabetes: a randomized, controlled trial. J Am Board Fam Med JABFM. 2009; 22(5):507-12. DOI: 10.3122/jabfm.2009.05.080093.
Crawford P, Crawford AJ. Edema from Taking Cinnamon for Treatment of Diabetes: Similar Biochemistry and Pathophysiology to Thiazolidinedione Medications. J Am Board Fam Med. 2018; 31(5):809-11. DOI: 10.3122/jabfm.2018.05.180024.
Blasco M, Ascaso JF. Control del perfil lipídico global. Clínica E Investig En Arterioscler. 2019; 31:34-41. DOI: 10.1016/j.arteri.2019.10.002.
Vafa M, Mohammadi F, Shidfar F, Sormaghi MS, Heidari I, Golestan B, et al. Effects of Cinnamon Consumption on Glycemic Status, Lipid Profile and Body Composition in Type 2 Diabetic Patients. Int J Prev Med. 2012; 3(8):531-6. PMCID: PMC3429799
Khan A, Safdar M, Ali Khan MM, Khattak KN, Anderson RA. Cinnamon Improves Glucose and Lipids of People With Type 2 Diabetes. Diabetes Care. 2003; 26(12):3215-8. DOI: 10.2337/diacare.26.12.3215.
Azimi P, Ghiasvand R, Feizi A, Hariri M, Abbasi B. Effects of Cinnamon, Cardamom, Saffron, and Ginger Consumption on Markers of Glycemic Control, Lipid Profile, Oxidative Stress, and Inflammation in Type 2 Diabetes Patients. Rev Diabet Stud RDS. 2014; 11(3-4):258-66. DOI: 10.1900/RDS.2014.11.258.
Permadi W, Hestiantoro A, Ritonga MA, Ferrina AI, Iswari WA, Sumapraia K, et al. Administration of Cinnamon and Lagersroemia speciosa Extract on Lipid Profile of Polycystic Ovarian Syndrome Women with High Body Mass Index. J Hum Reprod Sci. 2021; 14(1):16-20. DOI: 10.4103/jhrs.JHRS_141_20.
Santos HO, da Silva GAR. To what extent does cinnamon administration improve the glycemic and lipid profiles? Clin Nutr ESPEN. 2018; 27:1-9. DOI: 10.1016/j.clnesp.2018.07.011.
Maierean SM, Serban MC, Sahebkar A, Ursoniu S, Serban A, Penson P, et al. The effects of cinnamon supplementation on blood lipid concentrations: A systematic review and meta-analysis. J Clin Lipidol. 2017; 11(6):1393-406. DOI: 10.1016/j.jacl.2017.08.004.
Talat A. Effect of Cinnamon Extract on Blood Glucose Level and Lipid Profile in Alloxan Induced Diabetic Rats. Pak J Physiol [ 2011. Disponible en: https://www.academia.edu/42297481/Effect_of_Cinnamon_Extract_on_Blood_Glucose_Level_and_Lipid_Profile_in_Alloxan_Induced_Diabetic_Rats. DOI: 10.1016/j.jtcme.2014.12.005.
Baker WL, Gutierrez-Williams G, White CM, Kluger J, Coleman CI. Effect of cinnamon on glucose control and lipid parameters. Diabetes Care. 2008; 31(1):41-3. DOI: 10.2337/dc07-1711.
Namazi N, Khodamoradi K, Khamechi SP, Heshmati J, Ayati MH, Larijani B. The impact of cinnamon on anthropometric indices and glycemic status in patients with type 2 diabetes: A systematic review and meta-analysis of clinical trials. Complement Ther Med. 2019; 43:92-101. DOI: 10.1016/j.ctim.2019.01.002.
Keramati M, Musazadeh V, Malekahmadi M, Jamilian P, Jamilian P, Ghoreishi Z, et al. Cinnamon, an effective anti-obesity agent: Evidence from an umbrella meta-analysis. J Food Biochem. 2022; 46(8):e14166. DOI: 10.1111/jfbc.14166.
Zhu R, Liu H, Liu C, Wang L, Ma R, Chen B, et al. Cinnamaldehyde in diabetes: A review of pharmacology, pharmacokinetics and safety. Pharmacol Res. 2017;122:78-89. DOI: 10.1016/j.phrs.2017.05.019.
Mirfeizi M, Mehdizadeh Tourzani Z, Mirfeizi SZ, Asghari Jafarabadi M, Rezvani HR, Afzali M. Controlling type 2 diabetes mellitus with herbal medicines: A triple-blind randomized clinical trial of efficacy and safety. J Diabetes. 2016; 8(5):647-56. DOI: 10.1111/1753-0407.12342.
Jamali N, Jalali M, Saffari-Chaleshtori J, Samare-Najaf M, Samareh A. Effect of cinnamon supplementation on blood pressure and anthropometric parameters in patients with type 2 diabetes: A systematic review and meta-analysis of clinical trials. Diabetes Metab Syndr. 2020; 14(2):119-25. DOI: 10.1016/j.dsx.2020.01.009.
Silva ML, Bernardo MA, Singh J, de Mesquita MF. Cinnamon as a Complementary Therapeutic Approach for Dysglycemia and Dyslipidemia Control in Type 2 Diabetes Mellitus and Its Molecular Mechanism of Action: A Review. Nutrients. 2022; 14(13):2773. DOI: 10.3390/nu14132773.
Sahib AS. Anti-diabetic and antioxidant effect of cinnamon in poorly controlled type-2 diabetic Iraqi patients: A randomized, placebo-controlled clinical trial. J Intercult Ethnopharmacol. 2016; 5(2):108-13. DOI: 10.5455/jice.20160217044511.
Shalaby MA, Saifan HY. Some pharmacological effects of cinnamon and ginger herbs in obese diabetic rats. J Intercult Ethnopharmacol. 2019; 3(4): 144-149. DOI: 10.5455/jice.20140818050741.
Couturier K, Batandier C, Awada M, Hininger-Favier I, Canini F, Anderson RA, Leverve X, Roussel AM. Cinnamon improves insulin sensitivity and alters the body composition in an animal model of the metabolic syndrome. Arch Biochem Biophys. 2010; 501(1):158-161. DOI: 10.1016/j.abb.2010.05.032.
Qin B, Nagasaki M, Ren M, Bajotto G, Oshida Y, Sato Y. Cinnamon extract (traditional herb) potentiates in vivo insulin-regulated glucose utilization via enhancing insulin signaling in rats. Diabetes Res Clin Pract. 2003; 62:139-48. DOI: 10.1016/s0168-8227(03)00173-6
Kim SH, Hyun SH, Choung SY. Anti-diabetic effect of cinnamon extract on blood glucose in db/db mice. J Ethnopharmacol. 2006; 104:119-23. DOI: 10.1016/j.jep.2005.08.059
Hasanzade F, Toliat M, Emami SA, Emamimoghaadam Z. The Effect of Cinnamon on Glucose of Type II Diabetes Patients. J Tradit Complement Med. 2013; 3(3):171-4. DOI:10.4103/2225-4110.114900
Kang GG, Francis N, Hill R, Waters D, Blanchard C, Santhakumar AB. Dietary Polyphenols and Gene Expression in Molecular Pathways Associated with Type 2 Diabetes Mellitus: A Review. Int J Mol Sci. 2019; 21(1):E140. DOI: 10.3390/ijms21010140
Ranasinghe P, Jayawardana R, Galappaththy P, Constantine GR, de Vas Gunawardana N, Katulanda P. Efficacy and safety of «true» cinnamon (Cinnamomum zeylanicum) as a pharmaceutical agent in diabetes: a systematic review and meta-analysis. Diabet Med J Br Diabet Assoc. 2012; 29(12):1480-92. DOI: 10.1111/j.1464-5491.2012.03718.x
Bandara T, Uluwaduge I, Jansz ER. Bioactivity of cinnamon with special emphasis on diabetes mellitus: A review. Int J Food Sci Nutr. 2012; 63(3):380-6. DOI: 10.3109/09637486.2011.627849.
Talaei B, Amouzegar A, Sahranavard S, Hedayati M, Mirmiran P, Azizi F. Effects of Cinnamon Consumption on Glycemic Indicators, Advanced Glycation End Products, and Antioxidant Status in Type 2 Diabetic Patients. Nutrients. 2017; 9(9):991. DOI: 10.3390/nu9090991.
Wang J, Wang S, Yang J, Henning SM, Ezzat-Zadeh Z, Woo SL, et al. Acute Effects of Cinnamon Spice on Post-prandial Glucose and Insulin in Normal Weight and Overweight/Obese Subjects: A Pilot Study. Front Nutr. 2021; 7:619782. DOI: 10.3389/fnut.2020.619782.
Davari M, Hashemi R, Mirmiran P, Hedayati M, Sahranavard S, Bahreini S, et al. Effects of cinnamon supplementation on expression of systemic inflammation factors, NF-kB and Sirtuin-1 (SIRT1) in type 2 diabetes: a randomized, double blind, and controlled clinical trial. Nutr J. 2020; 19(1):1. DOI: 10.1186/s12937-019-0518-3.
Goldberg RB. Cytokine and cytokine-like inflammation markers, endothelial dysfunction, and imbalanced coagulation in development of diabetes and its complications. J Clin Endocr. 2009; 94(9): 3171–3182. DOI: 10.1210/jc.2008-2534.
Kirkham S, Akilen R, Sharma S, Tsiami A. The potential of cinnamon to reduce blood glucose levels in patients with type 2 diabetes and insulin resistance. Diabetes Obes Metab. 2009; 11(12):1100-13. DOI: 10.1111/j.1463-1326.2009.01094.x.
Cortez-Navarrete M, Pérez-Rubio KG, Escobedo-Gutiérrez M de J. Role of Fenugreek, Cinnamon, Curcuma longa, Berberine and Momordica charantia in Type 2 Diabetes Mellitus Treatment: A Review. Pharmaceuticals (Basel). 2023; 16(4):515. DOI: 10.3390/ph16040515.
Nuffer W, Tall Bull S, Bakhach H, Nuffer M. Sweetly Improving Sugars? Reviewing Cinnamon’s Effects on Blood Glucose. J Med Food. 2023; 26(1):68-73. DOI: 10.1089/jmf.2022.0073.
Rachid AP, Moncada M, de Mesquita MF, Brito J, Bernardo MA, Silva ML. Effect of Aqueous Cinnamon Extract on the Postprandial Glycemia Levels in Patients with Type 2 Diabetes Mellitus: A Randomized Controlled Trial. Nutrients. 2022; 14(8):1576. DOI: 10.3390/nu14081576.
Descargas
Publicado
Cómo citar
Número
Sección
Licencia
Derechos de autor 2023 Salutem Scientia Spiritus
Esta obra está bajo una licencia internacional Creative Commons Atribución-NoComercial-SinDerivadas 4.0.
La Revista Salutem Scientia Spiritus usa la licencia Creative Commons de Atribución – No comercial – Sin derivar: Los textos de la revista son posibles de ser descargados en versión PDF siempre que sea reconocida la autoría y el texto no tenga modificaciones de ningún tipo.
